Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Bell

Showing results (161-170 of 179) with videos related to

Pageof 18
Sort By:
Microbial Genomics|June 2, 2023
Pathogen genomics in public health laboratories: successes, challenges, and lessons learned from California's SARS-CoV-2 Whole-Genome Sequencing Initiative, California COVIDNetEmily A Smith, Kevin G Libuit, Curtis J Kapsak, et al.
Eclinicalmedicine|October 7, 2025
Laboratory evaluation of 185 commercial assays for detecting SARS-CoV-2: the UK response for mass testingAbbie Bown, Tim Peto, Angela Sweed, et al.
Cancer Immunology Research|December 8, 2025
A universal boosting strategy for adoptive T cell therapy using a paired vaccine/chimeric antigen receptorRebecca Burchett, Claire G Morris, Mira Ishak, et al.
The Lancet. Gastroenterology & Hepatology|March 12, 2022
A call for advocacy and patient voice to eliminate hepatitis B virus infectionPhilippa C Matthews, Kathryn Jack, Su Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity by Viral Load, S Gene Variants and Demographic Factors, and the Utility of Lateral Flow Devices to Prevent TransmissionLennard Y W Lee, Stefan Rozmanowski, Matthew Pang, et al.
Plos Pathogens|August 12, 2024
Genomic and functional determinants of host spectrum in Group B StreptococcusChiara Crestani, Taya L Forde, John Bell, et al.
Journal for Immunotherapy of Cancer|July 26, 2024
Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T-cell receptor signallingEdward Armstrong, Matthew K L Chiu, Shane Foo, et al.
Journal for Immunotherapy of Cancer|November 12, 2025
Effect of extracellular vesicles in remodeling the tumor microenvironment by DNMT1 downregulation for enhanced cancer immunotherapySalvatore Russo, Yvonne Giannoula, Sara Feola, et al.
Nature|November 23, 2007
Grand challenges in chronic non-communicable diseasesAbdallah S Daar, Peter A Singer, Deepa Leah Persad, et al.
Neuro-Oncology|April 16, 2013
Treating brain tumor-initiating cells using a combination of myxoma virus and rapamycinFranz J Zemp, Xueqing Lun, Brienne A McKenzie, et al.
Pageof 18

Showing results (161-170 of 179) with videos related to

Sort By:
Pageof 18
Microbial Genomics|June 2, 2023
Pathogen genomics in public health laboratories: successes, challenges, and lessons learned from California's SARS-CoV-2 Whole-Genome Sequencing Initiative, California COVIDNetEmily A Smith, Kevin G Libuit, Curtis J Kapsak, et al.
Eclinicalmedicine|October 7, 2025
Laboratory evaluation of 185 commercial assays for detecting SARS-CoV-2: the UK response for mass testingAbbie Bown, Tim Peto, Angela Sweed, et al.
Cancer Immunology Research|December 8, 2025
A universal boosting strategy for adoptive T cell therapy using a paired vaccine/chimeric antigen receptorRebecca Burchett, Claire G Morris, Mira Ishak, et al.
The Lancet. Gastroenterology & Hepatology|March 12, 2022
A call for advocacy and patient voice to eliminate hepatitis B virus infectionPhilippa C Matthews, Kathryn Jack, Su Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity by Viral Load, S Gene Variants and Demographic Factors, and the Utility of Lateral Flow Devices to Prevent TransmissionLennard Y W Lee, Stefan Rozmanowski, Matthew Pang, et al.
Plos Pathogens|August 12, 2024
Genomic and functional determinants of host spectrum in Group B StreptococcusChiara Crestani, Taya L Forde, John Bell, et al.
Journal for Immunotherapy of Cancer|July 26, 2024
Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T-cell receptor signallingEdward Armstrong, Matthew K L Chiu, Shane Foo, et al.
Journal for Immunotherapy of Cancer|November 12, 2025
Effect of extracellular vesicles in remodeling the tumor microenvironment by DNMT1 downregulation for enhanced cancer immunotherapySalvatore Russo, Yvonne Giannoula, Sara Feola, et al.
Nature|November 23, 2007
Grand challenges in chronic non-communicable diseasesAbdallah S Daar, Peter A Singer, Deepa Leah Persad, et al.
Neuro-Oncology|April 16, 2013
Treating brain tumor-initiating cells using a combination of myxoma virus and rapamycinFranz J Zemp, Xueqing Lun, Brienne A McKenzie, et al.
Pageof 18